Public Health

CLD offers Board Prep Practice Questions for liver disease care

Board Prep Practice Questions | Clinical Liver Disease

cdl-tweet-boardprep

Clinical Liver Disease (CLD) is an official digital learning resource of The American Association for the Study of Liver Diseases. This interactive, up-to-date source of education is designed for physicians and healthcare providers caring for the patient with liver disease.CLD offers a series of board-style question banks designed to help you determine which articles, videos, audiocasts, and issues are most useful to your practice.

Visit their site to access resources. MORE

HHS: Viral Hepatitis Action Plan Updates & Request for Support

Dear Colleagues,
 
We write for two reasons, to update you on our progress in developing and releasing the National Viral Hepatitis Action Plan for 2017 – 2020 and to ask for you to help us raise awareness of the HHS.gov/hepatitis website.
 
As you may recall, last April our federal partners met and agreed to develop an updated National Viral Hepatitis Action Plan (NVHAP). Since that time, we have worked with the 23 federal partners that compose the Viral Hepatitis Implementation Group. We have also worked diligently to capture key issues identified by our nonfederal partners. Although the process has been time intensive, the result will be an evidence-based, responsive road map for the nation to combat hepatitis B and hepatitis C for 2017 – 2020. The new NVHAP will identify measurable, aspirational 2020 goals and annual targets that will need to be met or exceeded if we are to achieve our goals.
 
Finalizing the Action Plan and preparing it for release has taken longer than anticipated. It is now in clearance and we hope to release the document in early 2017. We’ll follow up with you when a release date is established.
 
Last May, on National Hepatitis Testing Day, HHS launched our new viral hepatitis website, http://www.hhs.gov/hepatitis/. We write to ask for your help to raise awareness about these viral hepatitis pages by linking to them on your webpages. These dedicated viral hepatitis pages include resources such as:
 
· The Viral Hepatitis Action Plan and information about the federal agencies involved in its implementation and progress in achieving its goals
 
· Links to federal policies and guidelines that help advance our work to achieve national viral hepatitis goals
 
· The latest blog posts from HHS and community leaders on key viral hepatitis topics.
 
· Facts, data, tools, and training that individuals and community partners can use to help win the battle against viral hepatitis
 
· Online federal tools for assessing hepatitis risk and locating viral hepatitis testing and vaccine providers
 
The new HHS web pages provide easy access to viral hepatitis resources from across the federal government. The Viral Hepatitis Action Plan recognizes that achieving its goals will require active involvement of and by a broad mix of stakeholders from various sectors, including federal, state and local; both public and private. We are committed to continuing to expand the site and have plans for doing so in 2017. That is why we are asking you to help to raise awareness about these viral hepatitis pages and resources by placing a link to them on your webpages.
 
We’re also now on Twitter at: @HHS_ViralHep. Please join the viral hepatitis conversation online by following us. We share updated website content, upcoming Twitter chats, and other current opportunities to join efforts to implement the Viral Hepatitis Action Plan and to learn more about what others are doing in communities across the country.
 
Please check out this new resource in our fight against viral hepatitis and help us spread the word about the Viral Hepatitis Action Plan and advances in our national efforts to your communities.
 
Sincerely,

Rich Wolitski
Director
Office of HIV/AIDS and Infectious Disease Policy
Office of the Assistant Secretary for Health
Department of Health and Human Services
 
Corinna Dan
Viral Hepatitis Policy Advisor

Hepatitis C Infection Could Mean Heart Trouble

New article via John Hopkins Medicine

“People infected with the hepatitis C virus are at risk for liver damage, but the results of a new Johns Hopkins study now show the infection may also spell heart trouble…We have strong reason to believe that infection with hepatitis C fuels cardiovascular disease, independent of HIV and sets the stage for subsequent cardiovascular trouble,” says study principal investigator Eric Seaberg, Ph.D., assistant professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. “We believe our findings are relevant to anyone infected with hepatitis C regardless of HIV status.”

Want to read more?  Click the link-

http://www.hopkinsmedicine.org/news/media/releases/hepatitis_c_infection_may_fuel_heart_risk

Stopping the HIV Outbreak in Rural Indiana

http://www.nejm.org/doi/full/10.1056/NEJMp1507252#t=article

‘On March 26, 2015, Indiana Governor Mike Pence issued an executive order declaring a public health emergency in several counties across Indiana due to a rapidly escalating outbreak of human immunodeficiency virus (HIV).

In just a few short years, there has been a large increase in the number of young people abusing opiates. This increase in injection-drug use and the high rate of HIV and HCV transmission through drug injection means that needles are in short supply, and injection-drug users are turning to sharing needles.

Indiana is one of 25 states in the U.S. where it’s illegal to purchase syringes without a prescription and where state law does not authorize needle-exchange programs. Thus why Governor Pence declared a state of emergency, which enabled him to temporarily suspend the law and introduce a temporary needle-exchange program.

However, this needle-exchange program deters many people from participating because it requires that injection-drug users register with their initials and date of birth and unregistered injection-drug users are subject to prosecution for carrying syringes. (Using needles for non-medical purposes is a felony punishable by up to 3 years in prison.)

In order to prevent further HIV outbreaks among substance users, aggressive implementation of evidence-based practices for HIV prevention must be put in place. Permanently lifting the ban on using federal funds to support needle-exchange programs will be a critical component of HIV prevention, since these programs reduce HIV incidence.  The federal funding ban limits these programs scalability and quality of services, including their ability to provide on-site HIV and HCV testing and referrals for drug treatment.’

Synopsis of Threading the Needle — How to Stop the HIV Outbreak in Rural Indiana by Steffanie A. Strathdee, Ph.D., and Chris Beyrer, M.D., M.P.H.